Bone marrow (BM) is a highly complex tissue that provides important regulatory signals to
orchestrate hematopoiesis. Resident and transient cells occupy and interact with some well …

Myeloid sarcoma : Current Opinion in Hematology Myeloid sarcoma : Current Opinion in
Hematology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …

Background Extramedullary manifestations (EM) are rare in acute myeloid leukemia (AML)
and their impact on clinical outcomes is controversially discussed. Methods We …

Extramedullary (EM) colonization is a rare complication of acute myeloid leukemia (AML),
occurring in about 10% of patients, but the processes underlying tissue invasion are not …

Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour
mass of myeloid blasts occurring at an anatomical site other than the bone marrow, in most …

Disease progression in myelodysplastic syndromes (MDS), myelodysplastic-
myeloproliferative neoplasms (MDS/MPN), and myeloproliferative neoplasms (MPN) …

Background Myeloid sarcoma (MS), also known as chloroma, is an extramedullary
manifestation of malignant primitive myeloid cells. Previously, only small studies …

Aims Myeloid sarcoma (MS) is a rare extramedullary neoplasm composed of immature
myeloid precursor cells thought to be a unique clinical presentation of acute myeloid …

Chronic myeloid leukemia (CML) is a slow-growing type of cancer that originates in the
blood-forming cells of the bone marrow and is caused by a chromosomal mutation that is …

Summary Institutional database search (1999–2020) for acute myeloid leukaemia (AML)
identified 109 cases of myeloid sarcoma (MS), of which 19 were isolated and presented de …